US Stock MarketDetailed Quotes

Akari Therapeutics (AKTX)

Watchlist
  • 5.470
  • +0.070+1.29%
Close May 1 16:00 ET
  • 5.470
  • 0.0000.00%
Post 20:01 ET
6.26MMarket Cap-0.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akari Therapeutics (AKTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.81%-10.57M
-43.17%-3.04M
-42.35%-2.12M
33.47%-3.26M
46.83%-2.15M
23.61%-12.55M
51.83%-2.12M
39.16%-1.49M
-4.26%-4.89M
17.13%-4.04M
Net income from continuing operations
12.60%-17.3M
-40.46%-5.3M
-121.07%-6.4M
74.93%-1.9M
33.44%-3.71M
-97.75%-19.79M
8.84%-3.77M
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
Operating gains losses
237.70%2.52M
257.13%2.24M
501.06%758K
-367.66%-447K
92.99%-27K
73.30%-1.83M
-56.20%-1.42M
-179.41%-189K
127.97%167K
93.11%-385K
Depreciation and amortization
--0
--0
--0
--0
--0
250.00%14K
0.00%1K
--0
--0
1,200.00%13K
Deferred tax
---1.09M
--0
----
----
----
--0
--0
----
----
----
Other non cash items
-973.80%-2.37M
---470K
---681K
----
----
90.85%271K
----
----
----
----
Change In working capital
-106.18%-404K
-98.70%20K
-142.72%-575K
-120.27%-416K
-64.52%567K
855.08%6.54M
699.48%1.54M
1,203.28%1.35M
648.66%2.05M
383.84%1.6M
-Change in prepaid assets
-54.86%594K
0.00%202K
-68.69%129K
-68.26%179K
-39.13%84K
1,780.00%1.32M
-31.06%202K
795.65%412K
1,980.00%564K
157.74%138K
-Change in payables and accrued expense
-119.11%-998K
-113.57%-182K
-175.37%-704K
-139.99%-595K
-66.92%483K
658.01%5.22M
1,441.00%1.34M
655.95%934K
532.56%1.49M
550.62%1.46M
Cash from discontinued investing activities
Operating cash flow
15.81%-10.57M
-43.17%-3.04M
-42.35%-2.12M
33.47%-3.26M
46.83%-2.15M
23.61%-12.55M
51.83%-2.12M
39.16%-1.49M
-4.26%-4.89M
17.13%-4.04M
Investing cash flow
Cash flow from continuing investing activities
0
382K
Net business purchase and sale
--0
----
----
----
----
--382K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
----
----
----
----
--382K
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
19.87%13.17M
167.41%5.76M
528.22%1.9M
-56.45%3.38M
40.89%2.13M
56.52%10.99M
-38.75%2.15M
-443K
2,567.70%7.76M
-52.86%1.51M
Net issuance payments of debt
222.46%1.05M
87.46%-122K
664.58%1.9M
-131.99%-214K
-139.07%-514K
---855K
---973K
---336K
--669K
---215K
Net common stock issuance
-9.23%10.73M
54.92%4.85M
--0
-39.08%4.32M
-9.79%1.56M
68.40%11.82M
-10.98%3.13M
---133K
2,346.21%7.09M
-46.26%1.73M
Proceeds from stock option exercised by employees
69,850.00%1.4M
3,937.04%1.04M
--0
--363K
--0
-50.00%2K
-1,000.00%-27K
--26K
--0
--3K
Net other financing activities
----
----
----
----
--1.09M
--26K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
19.87%13.17M
167.41%5.76M
528.22%1.9M
-56.45%3.38M
40.89%2.13M
56.52%10.99M
-38.75%2.15M
---443K
2,567.70%7.76M
-52.86%1.51M
Net cash flow
Beginning cash position
-30.85%2.66M
13.27%2.54M
-33.66%2.77M
101.68%2.64M
-30.85%2.66M
-70.98%3.85M
-52.53%2.25M
-41.83%4.18M
-88.69%1.31M
-70.98%3.85M
Current changes in cash
320.22%2.6M
559.95%2.72M
88.41%-224K
-95.64%125K
99.33%-17K
87.44%-1.18M
146.19%412K
21.07%-1.93M
165.16%2.87M
-51.68%-2.53M
Effect of exchange rate changes
125.00%1K
--0
-250.00%-3K
300.00%4K
--0
-157.14%-4K
-83.33%1K
300.00%2K
-200.00%-2K
---5K
End cash Position
97.93%5.26M
97.93%5.26M
13.27%2.54M
-33.66%2.77M
101.68%2.64M
-30.85%2.66M
-30.85%2.66M
-52.53%2.25M
-41.83%4.18M
-88.69%1.31M
Free cash flow
15.81%-10.57M
-43.17%-3.04M
-42.35%-2.12M
33.47%-3.26M
46.83%-2.15M
23.61%-12.55M
51.83%-2.12M
39.16%-1.49M
-4.26%-4.89M
17.13%-4.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.81%-10.57M-43.17%-3.04M-42.35%-2.12M33.47%-3.26M46.83%-2.15M23.61%-12.55M51.83%-2.12M39.16%-1.49M-4.26%-4.89M17.13%-4.04M
Net income from continuing operations 12.60%-17.3M-40.46%-5.3M-121.07%-6.4M74.93%-1.9M33.44%-3.71M-97.75%-19.79M8.84%-3.77M-0.84%-2.9M-88.95%-7.56M-656.04%-5.57M
Operating gains losses 237.70%2.52M257.13%2.24M501.06%758K-367.66%-447K92.99%-27K73.30%-1.83M-56.20%-1.42M-179.41%-189K127.97%167K93.11%-385K
Depreciation and amortization --0--0--0--0--0250.00%14K0.00%1K--0--01,200.00%13K
Deferred tax ---1.09M--0--------------0--0------------
Other non cash items -973.80%-2.37M---470K---681K--------90.85%271K----------------
Change In working capital -106.18%-404K-98.70%20K-142.72%-575K-120.27%-416K-64.52%567K855.08%6.54M699.48%1.54M1,203.28%1.35M648.66%2.05M383.84%1.6M
-Change in prepaid assets -54.86%594K0.00%202K-68.69%129K-68.26%179K-39.13%84K1,780.00%1.32M-31.06%202K795.65%412K1,980.00%564K157.74%138K
-Change in payables and accrued expense -119.11%-998K-113.57%-182K-175.37%-704K-139.99%-595K-66.92%483K658.01%5.22M1,441.00%1.34M655.95%934K532.56%1.49M550.62%1.46M
Cash from discontinued investing activities
Operating cash flow 15.81%-10.57M-43.17%-3.04M-42.35%-2.12M33.47%-3.26M46.83%-2.15M23.61%-12.55M51.83%-2.12M39.16%-1.49M-4.26%-4.89M17.13%-4.04M
Investing cash flow
Cash flow from continuing investing activities 0382K
Net business purchase and sale --0------------------382K----------------
Cash from discontinued investing activities
Investing cash flow --0------------------382K----------------
Financing cash flow
Cash flow from continuing financing activities 19.87%13.17M167.41%5.76M528.22%1.9M-56.45%3.38M40.89%2.13M56.52%10.99M-38.75%2.15M-443K2,567.70%7.76M-52.86%1.51M
Net issuance payments of debt 222.46%1.05M87.46%-122K664.58%1.9M-131.99%-214K-139.07%-514K---855K---973K---336K--669K---215K
Net common stock issuance -9.23%10.73M54.92%4.85M--0-39.08%4.32M-9.79%1.56M68.40%11.82M-10.98%3.13M---133K2,346.21%7.09M-46.26%1.73M
Proceeds from stock option exercised by employees 69,850.00%1.4M3,937.04%1.04M--0--363K--0-50.00%2K-1,000.00%-27K--26K--0--3K
Net other financing activities ------------------1.09M--26K----------------
Cash from discontinued financing activities
Financing cash flow 19.87%13.17M167.41%5.76M528.22%1.9M-56.45%3.38M40.89%2.13M56.52%10.99M-38.75%2.15M---443K2,567.70%7.76M-52.86%1.51M
Net cash flow
Beginning cash position -30.85%2.66M13.27%2.54M-33.66%2.77M101.68%2.64M-30.85%2.66M-70.98%3.85M-52.53%2.25M-41.83%4.18M-88.69%1.31M-70.98%3.85M
Current changes in cash 320.22%2.6M559.95%2.72M88.41%-224K-95.64%125K99.33%-17K87.44%-1.18M146.19%412K21.07%-1.93M165.16%2.87M-51.68%-2.53M
Effect of exchange rate changes 125.00%1K--0-250.00%-3K300.00%4K--0-157.14%-4K-83.33%1K300.00%2K-200.00%-2K---5K
End cash Position 97.93%5.26M97.93%5.26M13.27%2.54M-33.66%2.77M101.68%2.64M-30.85%2.66M-30.85%2.66M-52.53%2.25M-41.83%4.18M-88.69%1.31M
Free cash flow 15.81%-10.57M-43.17%-3.04M-42.35%-2.12M33.47%-3.26M46.83%-2.15M23.61%-12.55M51.83%-2.12M39.16%-1.49M-4.26%-4.89M17.13%-4.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -